Role of Contrast Enhanced Spectral Mammography to Predict Upgrade Rates of Biopsy Proven Atypical Ductal Hyperplasia

NATerminatedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

May 10, 2018

Primary Completion Date

June 28, 2019

Study Completion Date

June 28, 2019

Conditions
Atypical Ductal Hyperplasia
Interventions
DEVICE

Contrast enhanced mammography

Contrast enhanced mammography is a new type of mammogram that uses contrast material combined with the mammogram to highlight areas that might be breast cancer and that could be missed on the mammogram alone.

Trial Locations (1)

02215

Beth Israel Deaconess Medical Center, Boston

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

GE Healthcare

INDUSTRY

lead

Dana-Farber Cancer Institute

OTHER